Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2018-03-01 Capital/Financing Update
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement and accompanying prospectus related to an offering of common stock by Sonoma Pharmaceuticals, Inc. It includes detailed information about the offering terms, risk factors, use of proceeds, and legal disclaimers. The document is filed pursuant to Rule 424(b)(3), which is a prospectus supplement filing under the Securities Act. This type of document is used to provide updated or additional information about a securities offering and is not a financial report, earnings release, or management discussion. It is a capital markets document related to fundraising and issuance of new shares. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full prospectus supplement, not just an announcement or brief notice, so it is not RPA or RNS. Confidence is high due to clear identification of the document type and regulatory references.
2018-03-01 English
FORM 10-Q
Interim / Quarterly Report Q3 2018
2018-02-14 English
SONOMA PHARMACEUTICALS
Major Shareholding Notification
2018-02-13 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 7, 2018, by Sonoma Pharmaceuticals, Inc. It announces the issuance of a press release with financial results for the fiscal quarter ended December 31, 2017, and includes a presentation used on the same date. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of such information. The length is 4229 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as a Regulatory Filing (RNS), which serves as a general announcement and does not contain the full financial report itself.
2018-02-07 English
OWNERSHIP DOCUMENT
Director's Dealing
2018-01-03 English
OWNERSHIP DOCUMENT
Director's Dealing
2018-01-03 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.